ProMIS Neurosciences Statistics

NASDAQ: PMNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.15+0.03 (+0.33%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

ProMIS Neurosciences by the numbers

ProMIS Neurosciences has a market capitalization of $82.1 million based on 8.97M shares outstanding. With trailing EPS of $-11.65, ProMIS Neurosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.7% below its 50-day average and 28.6% below its 200-day average.

Average daily trading volume is 84.01K shares, or about $768,692 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PMN valuation vs. peer median

PMN compared with the median of 8 peer companies
Metric	PMN	Peer median	Difference
Market cap	$82.05M	$76.39M	+7%
Avg. volume	84.01K	129.77K	-35%

Peer median across 8 companies: ACRV, TELO, RFL, OSTX, MNOV, INCR, LFVN, CTOR.

Valuation

Market cap: $82.05M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-11.65
Shares outstanding: 8.97M

Price and trading

Previous close: 9.12
Open: 9.15
Day range: 8.78 – 9.37
52-week range: 6.27 – 27.40
52-week change: -32.44%
50-day moving average: 13.20
200-day moving average: 12.82
Beta: —
Volume: 35.26K
Average volume: 84.01K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: Nov 13, 2026

Additional statistics

Market Cap: 82.05M
Forward Pe: -2.02
Eps: -11.65
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 27.40
Week52 Low: 6.27
Avg Volume: 84,010.00
Shares Outstanding: 8.97M
Ma50: 13.20
Ma200: 12.82
Earnings Date: Nov 13, 2026
Pct From52w High: -66.61%
Pct From52w Low: 45.93%